Division of Nephrology and Hypertension, Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan, USA.
Department of Pediatrics, Central Michigan University College of Medicine, Mount Pleasant, Michigan, USA.
Pediatr Transplant. 2023 Sep;27(6):e14576. doi: 10.1111/petr.14576. Epub 2023 Jul 13.
Restrictive lung disease leading to abnormal lung function in kidney transplant recipients is commonly associated with noninfectious complications or medications used for post-transplant immunosuppression. Herein, we report an interesting case of pediatric kidney transplant recipient with weight loss and abnormal spirometry who was diagnosed to have late-onset Pneumocystis pneumonia.
A 17-year-old male patient with a history of allergic rhinitis, mild persistent asthma, and deceased donor kidney transplant, performed 18 months prior, presented for routine evaluation of his asthma to the pulmonology clinic. He was clinically asymptomatic except for a weight loss of 8 kg over 6-month period prior to presentation. Patient's spirometry was suggestive of a restrictive pattern and further investigation using a high-resolution computed tomography (HRCT) of the chest showed bilateral diffuse ground-glass reticulonodular opacities with subpleural sparing suggestive of interstitial pneumonitis. A bronchoscopy with bronchoalveolar lavage revealed organisms consistent with Pneumocystis jirovecii on gomori-methenamine-silver (GMS) staining. Beta-d-glucan testing in serum revealed a level of >500 pg/mL (normal 0-59 pg/mL) further supportive of Pneumocystis jirovecii infection. Patient was treated with a 6-week course of trimethoprim-sulfamethoxazole. His weight loss and beta-d-glucan levels improved over a course of 6 months, and he continues to be on trimethoprim-sulfamethoxazole prophylaxis.
Late-onset Pneumocystis jirovecii infection in kidney transplant recipients can have an atypical presentation. Treating physicians should consider PJP in the differential diagnosis of unexplained weight loss in pediatric kidney transplant recipients, especially those receiving a large cumulative burden of immunosuppression.
导致肾移植受者肺功能异常的限制性肺病通常与非传染性并发症或用于移植后免疫抑制的药物有关。在此,我们报告了一例有趣的儿科肾移植受者病例,该患者体重减轻和肺功能检查异常,被诊断为迟发性肺囊虫肺炎。
一名 17 岁男性患者,有过敏性鼻炎、轻度持续性哮喘和已故供体肾移植史(18 个月前进行),因哮喘常规评估到肺病诊所就诊。他除了在就诊前 6 个月体重减轻 8 公斤外,临床上无症状。患者的肺功能检查提示为限制性模式,进一步进行胸部高分辨率计算机断层扫描(HRCT)显示双侧弥漫性磨玻璃网状结节状混浊,伴有胸膜下保留,提示间质性肺炎。支气管镜检查和支气管肺泡灌洗显示戈莫瑞-美蓝(GMS)染色符合卡氏肺孢子虫的生物体。血清β-d-葡聚糖检测显示水平>500 pg/mL(正常 0-59 pg/mL)进一步支持卡氏肺孢子虫感染。患者接受了 6 周的复方磺胺甲噁唑治疗。他的体重减轻和β-d-葡聚糖水平在 6 个月的疗程中得到改善,并且他继续接受复方磺胺甲噁唑预防。
肾移植受者迟发性卡氏肺孢子虫感染的表现可能不典型。治疗医生应在儿科肾移植受者不明原因体重减轻的鉴别诊断中考虑 PJP,尤其是那些接受大量累积免疫抑制治疗的患者。